Ground Coffee Recalled in 15 States for Caffeine Labeling Error
By I. Edwards HealthDay Reporter
MONDAY, March 31, 2025 -- The U.S. Food and Drug Administration (FDA) has recalled ground coffee sold in 15 states after finding it may have been wrongly labeled as decaffeinated.
Hundreds of 12-ounce bags of Our Family Traverse City Cherry Decaf Light Roast Ground Coffee were part of the recall.
These products were sold in Colorado, Iowa, Illinois, Indiana, Kansas, Kentucky, Missouri, Minnesota, North Carolina, North Dakota, Nebraska, Ohio, South Dakota, Wisconsin and Wyoming.
The company said no other products were affected.
“We are committed to your health and safety, and we follow best practices to ensure the quality and safety of the products we sell,” Our Family said, according to a report from NBC News. “We apologize for any inconvenience this may have caused.”
The recall was issued voluntarily March 13 by Massimo Zanetti Beverage USA, one of the country's largest coffee suppliers.
The FDA classified the event as a category II recall -- meaning it's “a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences.”
Massimo Zanetti and SpartanNash, the coffee's distributor, did not respond to requests for comment, NBC News said.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-04-01 06:00
Read more

- ViiV Healthcare’s Investigational Broadly Neutralising Antibody - N6LS - Successfully Maintains Viral Suppression in Long-Acting Treatment of HIV
- RFK Jr. Suggests Letting Bird Flu Spread
- Could Your Cup of Tea Help Remove Lead From Drinking Water?
- Adverse Outcomes Increased With Long-Term Inhaled Corticosteroids in COPD
- Weight Loss Greater With Intermittent Fasting Than Calorie Restriction
- Gastrointestinal Complications From Alcohol Increasing in Young People
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions